A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Wednesday, October 5 - Thursday, October 6 | Boston, MA & Virtual The inaugural International Conference on Newborn Sequencing, to be held October 5-6 in Boston, will explore how DNA sequencing is being implemented globally as a diagnostic and screening strategy for newborn children. Learn more and register on the event website. Please note: registration […]
Wednesday, June 7 | 8:30 a.m. - 5 p.m. ET | Washington, D.C. & Online On June 7, the Roundtable on Genomics and Precision Health at the National Academy of Sciences will host a hybrid public workshop examining the use of DNA sequencing as a supplement to traditional newborn screenings for treatable, but not yet […]
Roundtable on Genomics and Precision Health - Strategic Plan Reflection on the Roundtable's Work Since 2020 Wednesday, November 15 | 12 p.m. ET | Online The Roundtable on Genomics and Precision Health will host a virtual event to highlight the work of the Roundtable since the adoption of its strategic plan in 2020. Speakers will […]
GMKB